ProKidney Corp. Profile Avatar - Palmy Investing

ProKidney Corp.

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II cl…

Biotechnology
US, Winston-Salem [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

ProKidney Corp. can't present it's latest revenue by geo. area

Revenue By Geographic Areas

ProKidney Corp. can't present it's latest revenue by geo. area

Historical Revenue By Segment

Last 3Y, in mil. USD

ProKidney Corp. can't present revenue by segment

Historical Revenue By Geographic Area

Last 3Y, in mil. USD

ProKidney Corp. can't present revenue by geo. area

End of PROK's Analysis
CIK: 1850270 CUSIP: - ISIN: KYG7S53R1049 LEI: - UEI: -
Secondary Listings
PROK has no secondary listings inside our databases.